Agent for curing chronic obstructive pulmonary disease

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S150000

Reexamination Certificate

active

07932276

ABSTRACT:
The present invention provides a useful and highly safe agent for the treatment of chronic obstructive pulmonary disease, which contains, as the effective ingredient, at least one compound selected from the group consisting of thiazole derivatives and salts thereof represented by the general formula (1),wherein, R1is a phenyl group which may have 1 to 3 lower alkoxy groups as the substituents on the phenyl ring; R2is a pyridyl group which may have 1 to 3 carboxyl groups as the substituents on the pyridine ring.

REFERENCES:
patent: 2003/0013712 (2003-01-01), Tullis et al.
patent: 0513387 (1992-11-01), None
patent: 5051318 (1993-03-01), None
Hanania, N.A. “Inflammation in COPD: Can Anything Be Done?”, Medscape, Jun. 30, 2005.
Ohnishi et al. “Generation of tumor necrosis factor alpha by human nasal epithelial cells and inhibition by fluticasone propionate” Arerugi, Oct. 1995, pp. 1216-22; abstract provided.
Cazzola et al. “Additive Effects of Salmeterol and Fluticasone or Theophylline in COPD”, Chest, 2000, vol. 118, pp. 1576-1581.
Translation of the Office Action issued in the corresponding Egyptian application.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Agent for curing chronic obstructive pulmonary disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agent for curing chronic obstructive pulmonary disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for curing chronic obstructive pulmonary disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2676092

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.